BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8335680)

  • 1. Effects of tumor necrosis factor alpha, interferon alpha and interferon gamma on non-lymphoid leukemia cell lines: growth inhibition, differentiation induction and drug sensitivity modulation.
    Kikuchi A; Holán V; Minowada J
    Cancer Immunol Immunother; 1992; 35(4):257-63. PubMed ID: 1511460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interferon gamma and tumour necrosis factor alpha on sensitivity to cisplatin in ovarian carcinoma cell lines.
    Clark S; McGuckin MA; Hurst T; Ward BG
    Cancer Immunol Immunother; 1994 Aug; 39(2):100-4. PubMed ID: 8044830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and renal cell cancer: production, regulation, and growth effects.
    Koo AS; Armstrong C; Bochner B; Shimabukuro T; Tso CL; deKernion JB; Belldegrum A
    Cancer Immunol Immunother; 1992; 35(2):97-105. PubMed ID: 1596939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies.
    Massad LS; Mutch DG; Kao MS; Powell CB; Collins JL
    Cancer Immunol Immunother; 1991; 33(3):183-8. PubMed ID: 1904315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridine.
    Eda H; Fujimoto K; Watanabe S; Ishikawa T; Ohiwa T; Tatsuno K; Tanaka Y; Ishitsuka H
    Jpn J Cancer Res; 1993 Mar; 84(3):341-7. PubMed ID: 8486533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in mice.
    Puri RK; Rosenberg SA
    Cancer Immunol Immunother; 1989; 28(4):267-74. PubMed ID: 2495179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of proliferation of UM-SCV-1A and UM-SCV-6 vulvar carcinoma cells by cytokines.
    Vihko KK; Seppänen M; Henttinen T; Punnonen J; Grénman S; Punnonen R
    Cancer Immunol Immunother; 1997 Jan; 43(6):368-74. PubMed ID: 9067409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells.
    Iwasaki K; Toms SA; Barnett GH; Estes ML; Gupta MK; Barna BP
    Cancer Immunol Immunother; 1995 Apr; 40(4):228-34. PubMed ID: 7750120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the mechanisms of toxicity of the administration of recombinant tumor necrosis factor alpha in normal and tumor-bearing mice.
    Krosnick JA; McIntosh JK; Mulé JJ; Rosenberg SA
    Cancer Immunol Immunother; 1989; 30(3):133-8. PubMed ID: 2598182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia.
    Yamauchi N; Watanabe N; Maeda M; Okamoto T; Sasaki H; Tsuji N; Tsuji Y; Umeno H; Akiyama S; Niitsu Y
    Jpn J Cancer Res; 1992 May; 83(5):540-5. PubMed ID: 1319987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a human cell strain, KT, with high sensitivity to UV-killing and to cell proliferation inhibition by interferon.
    Suzuki N; Inaba N; Sugano I; Umehara S; Murakami T; Takakubo Y
    Jpn J Cancer Res; 1988 Nov; 79(11):1184-92. PubMed ID: 3147274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines.
    Ishihara J; Saijo N; Sasaki Y; Nakano H; Ozaki A; Takahashi H; Sakurai M; Nakagawa K; Iigo M; Kanzawa F
    Cancer Immunol Immunother; 1987; 24(3):185-9. PubMed ID: 3594481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro.
    Parry HJ; Rees RC
    Cancer Immunol Immunother; 1992; 34(6):355-60. PubMed ID: 1563012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
    Denton NL; Chen CY; Scott TR; Cripe TP
    Biomedicines; 2016 Jul; 4(3):. PubMed ID: 28536380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells.
    van Valen F; Kentrup-Lardong V; Truckenbrod B; Rübe C; Winkelmann W; Jürgens WW
    J Cancer Res Clin Oncol; 1997; 123(5):245-52. PubMed ID: 9201246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effects of interferon gamma in combination with alpha-difluoromethylornithine on human carcinoma cell cultures.
    Klouche M; Kirchner H; Hölzel F
    J Cancer Res Clin Oncol; 1994; 120(12):700-6. PubMed ID: 7798293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro.
    van Valen F; Winkelmann W; Burdach S; Göbel U; Jürgens H
    J Cancer Res Clin Oncol; 1993; 119(10):615-21. PubMed ID: 8335680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line.
    Raitano AB; Korc M
    J Biol Chem; 1990 Jun; 265(18):10466-72. PubMed ID: 2141333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells.
    Raitano AB; Scuderi P; Korc M
    Pancreas; 1990 May; 5(3):267-77. PubMed ID: 2111548
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.